IVR INTERVENTION TO IMPROVE ADHERENCE TO IC MEDS IN ADULTS WITH ASTHMA

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目及 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者的研究机构。 这是一项研究，旨在观察每天服用皮质类固醇的成人哮喘患者是否会更好地按照医生的处方服用哮喘药物。 为了确定这是否属实，将从NJ IRB批准的数据库中招募50名参与者参与本研究。 这些参与者将与研究小组会面两次。 在第一次访问时，他们将完成2份问卷;一份关于哮喘生活质量，另一份关于对药物的信念。 研究小组还将在受试者身上放置一个微芯片哮喘跟踪设备？每日哮喘药物。 参加者将被分为两组。 干预组将收到3或4个自动支持电话，提醒他们的医生？？的治疗计划，并询问他们是否填写了他们的处方。 控制组不会接到任何电话。 这将在10周内发生。 10周后，受试者将返回新泽西州，在那里他或她将再次完成问卷调查，并收集哮喘跟踪设备。 将收集和测量来自跟踪设备和问卷回答的数据，以确定电话干预是否对参与者如何使用哮喘药物及其哮喘相关生活质量产生影响。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a study designed to look at whether or not adult patients with asthma who are on a daily prescribed corticosteroid will do a better job of taking their asthma medication as prescribed by their doctor. To see if this is true 50 participants will be recruited from a NJ IRB approved database to participate in this study. These participants will meet with the research team twice. On the first visit they will complete 2 questionnaires; one about asthma quality of life and the second about beliefs about medications. The research team will also place a micro-chipped asthma tracking device on the subject¿??s daily asthma medication. The participants will be divided into two groups. The intervention group will receive 3 or 4 automated supportive phone calls reminding them of their doctor¿??s treatment plan and asking if they filled their prescription. The control group will receive no phone calls. This will happen over a period of 10 weeks. After 10 weeks the participant will return to NJ where he or she will again complete the questionnaires and the asthma tracking device will be collected. The data from the tracking device and questionnaire responses will be collected and measured to determine if the telephone intervention has had an effect on how the participants used their asthma medication and their asthma related quality of life.